356 related articles for article (PubMed ID: 23445543)
1. Sirtuins as possible drug targets in type 2 diabetes.
Kitada M; Kume S; Kanasaki K; Takeda-Watanabe A; Koya D
Curr Drug Targets; 2013 Jun; 14(6):622-36. PubMed ID: 23445543
[TBL] [Abstract][Full Text] [Related]
2. Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function.
Kitada M; Ogura Y; Monno I; Koya D
Front Endocrinol (Lausanne); 2019; 10():187. PubMed ID: 30972029
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential.
Kitada M; Koya D
Diabetes Metab J; 2013 Oct; 37(5):315-25. PubMed ID: 24199159
[TBL] [Abstract][Full Text] [Related]
4. SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications.
Kume S; Uzu T; Kashiwagi A; Koya D
Endocr Metab Immune Disord Drug Targets; 2010 Mar; 10(1):16-24. PubMed ID: 20044906
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 and insulin resistance.
Liang F; Kume S; Koya D
Nat Rev Endocrinol; 2009 Jul; 5(7):367-73. PubMed ID: 19455179
[TBL] [Abstract][Full Text] [Related]
6. Sirtuin 6, a possible therapeutic target for type 2 diabetes.
Bae EJ
Arch Pharm Res; 2017 Dec; 40(12):1380-1389. PubMed ID: 29177584
[TBL] [Abstract][Full Text] [Related]
7. Sirtuins and Insulin Resistance.
Zhou S; Tang X; Chen HZ
Front Endocrinol (Lausanne); 2018; 9():748. PubMed ID: 30574122
[TBL] [Abstract][Full Text] [Related]
8. The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus.
Chen J; Wang Q; Li R; Li Z; Jiang Q; Yan F; Ye J
Life Sci; 2023 Nov; 333():122187. PubMed ID: 37858715
[TBL] [Abstract][Full Text] [Related]
9. A novel SIRT1 activator E6155 improves insulin sensitivity in type 2 diabetic KKA
Liu P; Feng T; Zuo X; Wang X; Luo J; Li N; Han X; Zhu N; Xu S; Xu Y; Jin ZG; Si S
Biochem Biophys Res Commun; 2018 Apr; 498(3):633-639. PubMed ID: 29524414
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 and insulin resistance.
Cao Y; Jiang X; Ma H; Wang Y; Xue P; Liu Y
J Diabetes Complications; 2016; 30(1):178-83. PubMed ID: 26422395
[TBL] [Abstract][Full Text] [Related]
11. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.
Kitada M; Kume S; Takeda-Watanabe A; Kanasaki K; Koya D
Clin Sci (Lond); 2013 Feb; 124(3):153-64. PubMed ID: 23075334
[TBL] [Abstract][Full Text] [Related]
12. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
Milne JC; Lambert PD; Schenk S; Carney DP; Smith JJ; Gagne DJ; Jin L; Boss O; Perni RB; Vu CB; Bemis JE; Xie R; Disch JS; Ng PY; Nunes JJ; Lynch AV; Yang H; Galonek H; Israelian K; Choy W; Iffland A; Lavu S; Medvedik O; Sinclair DA; Olefsky JM; Jirousek MR; Elliott PJ; Westphal CH
Nature; 2007 Nov; 450(7170):712-6. PubMed ID: 18046409
[TBL] [Abstract][Full Text] [Related]
13. Sirtuins in gamete biology and reproductive physiology: emerging roles and therapeutic potential in female and male infertility.
Tatone C; Di Emidio G; Barbonetti A; Carta G; Luciano AM; Falone S; Amicarelli F
Hum Reprod Update; 2018 May; 24(3):267-289. PubMed ID: 29447380
[TBL] [Abstract][Full Text] [Related]
14. SIRT1: a promising therapeutic target in type 2 diabetes mellitus.
Mihanfar A; Akbarzadeh M; Ghazizadeh Darband S; Sadighparvar S; Majidinia M
Arch Physiol Biochem; 2024 Feb; 130(1):13-28. PubMed ID: 34379994
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
16. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction.
Haigis MC; Guarente LP
Genes Dev; 2006 Nov; 20(21):2913-21. PubMed ID: 17079682
[TBL] [Abstract][Full Text] [Related]
17. Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?
Song J; Yang B; Jia X; Li M; Tan W; Ma S; Shi X; Feng L
Front Endocrinol (Lausanne); 2018; 9():724. PubMed ID: 30559718
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of sirtuins in cardiovascular diseases: from bench to bedside.
Winnik S; Auwerx J; Sinclair DA; Matter CM
Eur Heart J; 2015 Dec; 36(48):3404-12. PubMed ID: 26112889
[TBL] [Abstract][Full Text] [Related]
19. Proposed Tandem Effect of Physical Activity and Sirtuin 1 and 3 Activation in Regulating Glucose Homeostasis.
Pacifici F; Di Cola D; Pastore D; Abete P; Guadagni F; Donadel G; Bellia A; Esposito E; Salimei C; Sinibaldi Salimei P; Ricordi C; Lauro D; Della-Morte D
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557786
[TBL] [Abstract][Full Text] [Related]
20. Bovine sirtuins: initial characterization and expression of sirtuins 1 and 3 in liver, muscle, and adipose tissue.
Ghinis-Hozumi Y; González-Gallardo A; González-Dávalos L; Antaramian A; Villarroya F; Shimada A; Varela-Echavarría A; Mora O
J Anim Sci; 2011 Aug; 89(8):2529-36. PubMed ID: 21421831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
